BACKGROUND. Ataxia-telangiectasia is an autosomal recessive syndrome in which cancers develop in affected homozygotes at a rate approximately 100 times higher than in unaffected age-matched subjects. Retrospective studies have shown that persons heterozygous for the ataxia-telangiectasia gene, who make up about 1 percent of the general population, also have an excess risk of cancer, particularly breast cancer in women. Patients with ataxia-telangiectasia and cells derived from homozygotes and heterozygotes are unusually sensitive to ionizing radiation. METHODS. Cancer incidence and mortality, mortality from ischemic heart disease, and mortality from all causes were compared prospectively for a mean of 6.4 years in 1599 adult blood relatives of patients with ataxia-telangiectasia and 821 of their spouses, who served as controls, in 161 families affected by ataxia-telangiectasia. In a case-control substudy, we compared documented occupational and fluoroscopic diagnostic exposures to radiation in the 19 female blood relatives in whom breast cancer was first diagnosed during the period of prospective observation with the exposures in 57 matched blood relatives who did not have breast cancer. RESULTS. Cancer rates were significantly higher in the group of blood relatives than in their spouses, specifically in the subgroup of 294 blood relatives who were known to be heterozygous for the ataxia-telangiectasia gene. The estimated risk of cancer of all types among heterozygotes as compared with noncarriers was 3.8 in men and 3.5 in women, and that for breast cancer in women was 5.1. Among the blood relatives, women with breast cancer were more likely to have been exposed to selected sources of ionizing radiation than controls without cancer (odds ratio = 5.8, P = 0.005). Male and female blood relatives also had 3-fold and 2.6-fold excess mortality from all causes, respectively, from the ages of 20 through 59 years. CONCLUSIONS. The ataxia-telangiectasia gene predisposes heterozygotes to cancer, particularly breast cancer in women. There is also excess mortality from all causes in adults under the age of 60. Diagnostic or occupational exposure to ionizing radiation probably increases the risk of breast cancer in women heterozygous for ataxia-telangiectasia.
Source Information
Biological Sciences Research Center, University of North Carolina, Chapel Hill 27599-7250.
This article has been cited by other articles:
Flanagan, J. M., Munoz-Alegre, M., Henderson, S., Tang, T., Sun, P., Johnson, N., Fletcher, O., dos Santos Silva, I., Peto, J., Boshoff, C., Narod, S., Petronis, A.
(2009). Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet
18: 1332-1342
[Abstract][Full Text]
Swift, M., Lukin, J. L.
(2008). Breast Cancer Incidence and the Effect of Cigarette Smoking in Heterozygous Carriers of Mutations in the Ataxia-Telangiectasia Gene. Cancer Epidemiol. Biomarkers Prev.
17: 3188-3192
[Abstract][Full Text]
Concannon, P., Haile, R. W., Borresen-Dale, A.-L., Rosenstein, B. S., Gatti, R. A., Teraoka, S. N., Diep, A. T., Jansen, L., Atencio, D. P., Langholz, B., Capanu, M., Liang, X., Begg, C. B., Thomas, D. C., Bernstein, L., Olsen, J. H., Malone, K. E., Lynch, C. F., Anton-Culver, H., Bernstein, J. L., for the Women's Environment, Cancer, and Radiation,
(2008). Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer. Cancer Res.
68: 6486-6491
[Abstract][Full Text]
Dombernowsky, S. L., Weischer, M., Allin, K. H., Bojesen, S. E., Tybjjrg-Hansen, A., Nordestgaard, B. G.
(2008). Risk of Cancer by ATM Missense Mutations in the General Population. JCO
26: 3057-3062
[Abstract][Full Text]
Ho, E. L. Y., Parent, M., Satoh, M. S.
(2007). Induction of Base Damages Representing a High Risk Site for Double-strand DNA Break Formation in Genomic DNA by Exposure of Cells to DNA Damaging Agents. J. Biol. Chem.
282: 21913-21923
[Abstract][Full Text]
Lavin, M. F., Gueven, N., Bottle, S., Gatti, R. A.
(2007). Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull
0: ldm012v1-20
[Abstract][Full Text]
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Bialkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., Smith, G. C.M., Ashworth, A.
(2006). Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition. Cancer Res.
66: 8109-8115
[Abstract][Full Text]
Lord, C. J., Garrett, M. D., Ashworth, A.
(2006). Targeting the Double-Strand DNA Break Repair Pathway as a Therapeutic Strategy. Clin. Cancer Res.
12: 4463-4468
[Abstract][Full Text]
Bernstein, J. L., Teraoka, S. N., John, E. M., Andrulis, I. L., Knight, J. A., Lapinski, R., Olson, E. R., Wolitzer, A. L., Seminara, D., Whittemore, A. S., Concannon, P.
(2006). The CHEK2*1100delC Allelic Variant and Risk of Breast Cancer: Screening Results from the Breast Cancer Family Registry.. Cancer Epidemiol. Biomarkers Prev.
15: 348-352
[Abstract][Full Text]
Millikan, R. C., Player, J. S., deCotret, A. R., Tse, C.-K., Keku, T.
(2005). Polymorphisms in DNA Repair Genes, Medical Exposure to Ionizing Radiation, and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
14: 2326-2334
[Abstract][Full Text]
Bowen, T.J., Yakushiji, H., Montagna, C., Jain, S., Ried, T., Wynshaw-Boris, A.
(2005). Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching. Cancer Res.
65: 8736-8746
[Abstract][Full Text]
Taylor, A M R, Byrd, P J
(2005). Molecular pathology of ataxia telangiectasia. J. Clin. Pathol.
58: 1009-1015
[Abstract][Full Text]
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., Easton, D. F.
(2005). Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers. JNCI J Natl Cancer Inst
97: 813-822
[Abstract][Full Text]
Butch, A. W., Chun, H. H., Nahas, S. A., Gatti, R. A.
(2004). Immunoassay to Measure Ataxia-Telangiectasia Mutated Protein in Cellular Lysates. Clin. Chem.
50: 2302-2308
[Abstract][Full Text]
Petereit, D. G., Rogers, D., Govern, F., Coleman, N., Osburn, C. H., Howard, S. P., Kaur, J., Burhansstipanov, L., Fowler, C. J. F., Chappell, R., Mehta, M. P.
(2004). Increasing Access to Clinical Cancer Trials and Emerging Technologies for Minority Populations: The Native American Project. JCO
22: 4452-4455
[Full Text]
Momani, M. S., Shore-Freedman, E., Collins, B. J., Lubin, J., Ron, E., Schneider, A. B.
(2004). Familial Concordance of Thyroid and Other Head and Neck Tumors in an Irradiated Cohort: Analysis of Contributing Factors. J. Clin. Endocrinol. Metab.
89: 2185-2191
[Abstract][Full Text]
Szabo, C. I., Schutte, M., Broeks, A., Houwing-Duistermaat, J. J., Thorstenson, Y. R., Durocher, F., Oldenburg, R. A., Wasielewski, M., Odefrey, F., Thompson, D., Floore, A. N., Kraan, J., Klijn, J. G. M., van den Ouweland, A. M. W., Wagner, T. M. U., Devilee, P., Simard, J., van 't Veer, L. J., Goldgar, D. E., Meijers-Heijboer, H.
(2004). Are ATM Mutations 7271T->G and IVS10-6T->G Really High-Risk Breast Cancer-Susceptibility Alleles?. Cancer Res.
64: 840-843
[Abstract][Full Text]
Thull, D. L., Vogel, V. G.
(2004). Recognition and Management of Hereditary Breast Cancer Syndromes. The Oncologist
9: 13-24
[Abstract][Full Text]
Takagi, M., Tsuchida, R., Oguchi, K., Shigeta, T., Nakada, S., Shimizu, K., Ohki, M., Delia, D., Chessa, L., Taya, Y., Nakanishi, M., Tsunematsu, Y., Bessho, F., Isoyama, K., Hayashi, Y., Kudo, K., Okamura, J., Mizutani, S.
(2004). Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease. Blood
103: 283-290
[Abstract][Full Text]
Brenner, D. J., Doll, R., Goodhead, D. T., Hall, E. J., Land, C. E., Little, J. B., Lubin, J. H., Preston, D. L., Preston, R. J., Puskin, J. S., Ron, E., Sachs, R. K., Samet, J. M., Setlow, R. B., Zaider, M.
(2003). Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc. Natl. Acad. Sci. USA
100: 13761-13766
[Abstract][Full Text]
Bretsky, P., Haiman, C. A., Gilad, S., Yahalom, J., Grossman, A., Paglin, S., Van Den Berg, D., Kolonel, L. N., Skaliter, R., Henderson, B. E.
(2003). The Relationship between Twenty Missense ATM Variants and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol. Biomarkers Prev.
12: 733-738
[Abstract][Full Text]
Ju, R., Muller, M. T.
(2003). Histone Deacetylase Inhibitors Activate p21WAF1 Expression via ATM. Cancer Res.
63: 2891-2897
[Abstract][Full Text]
Oguchi, K., Takagi, M., Tsuchida, R., Taya, Y., Ito, E., Isoyama, K., Ishii, E., Zannini, L., Delia, D., Mizutani, S.
(2003). Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood
101: 3622-3627
[Abstract][Full Text]
Rauscher, G. H., Sandler, D. P., Poole, C., Pankow, J., Shore, D., Bloomfield, C. D., Olshan, A. F.
(2003). Is Family History of Breast Cancer a Marker of Susceptibility to Exposures in the Incidence of de Novo Adult Acute Leukemia?. Cancer Epidemiol. Biomarkers Prev.
12: 289-294
[Abstract][Full Text]
Monteiro, A N A, Zhang, S, Phelan, C M, Narod, S A
(2003). Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families. J. Med. Genet.
40: e51-51
[Full Text]
Lynch, H. T., Snyder, C. L., Lynch, J. F., Riley, B. D., Rubinstein, W. S.
(2003). Hereditary Breast-Ovarian Cancer at the Bedside: Role of the Medical Oncologist. JCO
21: 740-753
[Abstract][Full Text]
Eckardt, N. A.
(2003). ATM to the Rescue: Repairing DNA Damage. Plant Cell
15: 1-3
[Full Text]
Offit, K., Gilad, S., Paglin, S., Kolachana, P., Roisman, L. C., Nafa, K., Yeugelewitz, V., Gonzales, M., Robson, M., McDermott, D., Pierce, H. H., Kauff, N. D., Einat, P., Jhanwar, S., Satagopan, J. M., Oddoux, C., Ellis, N., Skaliter, R., Yahalom, J.
(2002). Rare Variants of ATM and Risk for Hodgkin's Disease and Radiation-associated Breast Cancers. Clin. Cancer Res.
8: 3813-3819
[Abstract][Full Text]
Maillet, P, Bonnefoi, H, Vaudan-Vutskits, G, Pajk, B, Cufer, T, Foulkes, W D, Chappuis, P O, Sappino, A-P
(2002). Constitutional alterations of the ATM gene in early onset sporadic breast cancer. J. Med. Genet.
39: 751-753
[Full Text]
Humphrey, L. L., Helfand, M., Chan, B. K.S., Woolf, S. H.
(2002). Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
137: 347-360
[Abstract][Full Text]
Gronbak, K., Worm, J., Ralfkiaer, E., Ahrenkiel, V., Hokland, P., Guldberg, P.
(2002). ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood
100: 1430-1437
[Abstract][Full Text]
Worgul, B. V., Smilenov, L., Brenner, D. J., Junk, A., Zhou, W., Hall, E. J.
(2002). Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc. Natl. Acad. Sci. USA
99: 9836-9839
[Abstract][Full Text]
de Jong, M M, Nolte, I M, te Meerman, G J, van der Graaf, W T A, Oosterwijk, J C, Kleibeuker, J H, Schaapveld, M, de Vries, E G E
(2002). Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J. Med. Genet.
39: 225-242
[Abstract][Full Text]
Chenevix-Trench, G., Spurdle, A. B., Gatei, M., Kelly, H., Marsh, A., Chen, X., Donn, K., Cummings, M., Nyholt, D., Jenkins, M. A., Scott, C., Pupo, G. M., Dork, T., Bendix, R., Kirk, J., Tucker, K., McCredie, M. R. E., Hopper, J. L., Sambrook, J., Mann, G. J., Khanna, K. K.
(2002). Dominant Negative ATM Mutations in Breast Cancer Families. JNCI J Natl Cancer Inst
94: 205-215
[Abstract][Full Text]
Scott, S. P., Bendix, R., Chen, P., Clark, R., Dork, T., Lavin, M. F.
(2002). Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc. Natl. Acad. Sci. USA
99: 925-930
[Abstract][Full Text]
Dork, T., Bendix, R., Bremer, M., Rades, D., Klopper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., Weise, S., Stuhrmann, M., Karstens, J. H.
(2001). Spectrum of ATM Gene Mutations in a Hospital-based Series of Unselected Breast Cancer Patients. Cancer Res.
61: 7608-7615
[Abstract][Full Text]
Boultwood, J
(2001). Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J. Clin. Pathol.
54: 512-516
[Abstract][Full Text]
Nathanson, K. L., Weber, B. L.
(2001). 'Other' breast cancer susceptibility genes: searching for more holy grail. Hum Mol Genet
10: 715-720
[Abstract][Full Text]
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., Krause, D. A., Kuske, R. R., Langer, A. S., Sledge, G. W. Jr, Whelan, T. J., Pfister, D. G.
(2001). Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology. JCO
19: 1539-1569
[Abstract][Full Text]
Swift, M.
(2001). Public Health Burden of Cancer in Ataxia-Telangiectasia Heterozygotes. JNCI J Natl Cancer Inst
93: 84-85
[Full Text]
Olsen, J. H., Hahnemann, J. M., Borresen-Dale, A.-L., Brondum-Nielsen, K., Hammarstrom, L., Kleinerman, R., Kaariainen, H., Lonnqvist, T., Sankila, R., Seersholm, N., Tretli, S., Yuen, J., Boice, J. D. Jr., Tucker, M.
(2001). Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries. JNCI J Natl Cancer Inst
93: 121-127
[Abstract][Full Text]
Haber, D.
(2000). Roads Leading to Breast Cancer. NEJM
343: 1566-1568
[Full Text]
Su, Y., Swift, M.
(2000). Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles. ANN INTERN MED
133: 770-778
[Abstract][Full Text]
Martin, A.-M., Weber, B. L.
(2000). Genetic and Hormonal Risk Factors in Breast Cancer. JNCI J Natl Cancer Inst
92: 1126-1135
[Abstract][Full Text]
Emilien, G., Ponchon, M., Caldas, C., Isacson, O., Maloteaux, J.-M.
(2000). Impact of genomics on drug discovery and clinical medicine. QJM
93: 391-423
[Abstract][Full Text]
Stoppa-Lyonnet, D., Lauge, A., Sigaux, F., Stern;, M.-H., Vanasse, G. J., Concannon, P., Willerford, D. M.
(2000). No germline ATM mutation in a series of 16 T-cell prolymphocytic leukemias. Blood
96: 374-377
[Full Text]
Gatei, M., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B., Khanna, K. K.
(2000). Role for ATM in DNA Damage-induced Phosphorylation of BRCA1. Cancer Res.
60: 3299-3304
[Abstract][Full Text]
Khanna, K. K.
(2000). Cancer Risk and the ATM Gene: a Continuing Debate. JNCI J Natl Cancer Inst
92: 795-802
[Abstract][Full Text]
Lakhani, S. R., Gusterson, B. A., Jacquemier, J., Sloane, J. P., Anderson, T. J., van de Vijver, M. J., Venter, D., Freeman, A., Antoniou, A., McGuffog, L., Smyth, E., Steel, C. M., Haites, N., Scott, R. J., Goldgar, D., Neuhausen, S., Daly, P. A., Ormiston, W., McManus, R., Scherneck, S., Ponder, B. A. J., Futreal, P. A., Peto, J., Stoppa-Lyonnet, D., Bignon, Y.-J., Struewing, J. P., Bishop, D. T., Klijn, J. G. M., Devilee, P., Cornelisse, C. J., Lasset, C., Lenoir, G., Barkardottir, R. B., Egilsson, V., Hamann, U., Chang-Claude, J., Sobol, H., Weber, B., Easton, D. F., Stratton, M. R.
(2000). The Pathology of Familial Breast Cancer: Histological Features of Cancers in Families Not Attributable to Mutations in BRCA1 or BRCA2. Clin. Cancer Res.
6: 782-789
[Abstract][Full Text]
Houlston, R S, Tomlinson, I P M
(2000). Detecting low penetrance genes in cancer: the way ahead. J. Med. Genet.
37: 161-167
[Abstract][Full Text]
Kim, S.-T., Lim, D.-S., Canman, C. E., Kastan, M. B.
(1999). Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members. J. Biol. Chem.
274: 37538-37543
[Abstract][Full Text]
Coughlin, S. S., Piper, M.
(1999). Genetic Polymorphisms and Risk of Breast Cancer. Cancer Epidemiol. Biomarkers Prev.
8: 1023-1032
[Full Text]
Turker, M. S., Gage, B. M., Rose, J. A., Ponomareva, O. N., Tischfield, J. A., Stambrook, P. J., Barlow, C., Wynshaw-Boris, A.
(1999). Solid Tissues Removed from Atm Homozygous Deficient Mice Do Not Exhibit a Mutator Phenotype for Second-Step Autosomal Mutations. Cancer Res.
59: 4781-4783
[Abstract][Full Text]
Schaffner, C., Stilgenbauer, S., Rappold, G. A., Dohner, H., Lichter, P.
(1999). Somatic ATM Mutations Indicate a Pathogenic Role of ATM in B-Cell Chronic Lymphocytic Leukemia. Blood
94: 748-753
[Abstract][Full Text]
Cloos, J., Nieuwenhuis, E. J. C., Boomsma, D. I., Kuik, D. J., van der Sterre, M. L. T., Arwert, F., Snow, G. B., Braakhuis, B. J. M.
(1999). Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes. JNCI J Natl Cancer Inst
91: 1125-1130
[Abstract][Full Text]
Mossmana, K L, Ledesma, L M
(1999). Radiation exposure and adaptive processes. Hum Exp Toxicol
18: 436-439
Shigeta, T., Takagi, M., Delia, D., Chessa, L., Iwata, S., Kanke, Y., Asada, M., Eguchi, M., Mizutani, S.
(1999). Defective Control of Apoptosis and Mitotic Spindle Checkpoint in Heterozygous Carriers of ATM Mutations. Cancer Res.
59: 2602-2607
[Abstract][Full Text]
Nichols, K. E., Levitz, S., Shannon, K. E., Wahrer, D. C.R., Bell, D. W., Chang, G., Hegde, S., Neuberg, D., Shafman, T., Tarbell, N. J., Mauch, P., Ishioka, C., Haber, D. A., Diller, L.
(1999). Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease. JCO
17: 1259-1259
[Abstract][Full Text]
Swift, M., Su, Y.
(1999). Link between breast cancer and ATM gene is strong. BMJ
318: 400-400
[Full Text]
Gately, D. P., Hittle, J. C., Chan, G. K. T., Yen, T. J.
(1998). Characterization of ATM Expression, Localization, and Associated DNA-dependent Protein Kinase Activity. Mol. Biol. Cell
9: 2361-2374
[Abstract][Full Text]
Lavin, M.
(1998). Role of the ataxia-telangiectasia gene (ATM) in breast cancer. BMJ
317: 486-487
[Full Text]
Newsham, I. F.
(1998). The Long and Short of Chromosome 11 in Breast Cancer. Am. J. Pathol.
153: 5-9
[Full Text]
Cabana, M. D., Crawford, T. O., Winkelstein, J. A., Christensen, J. R., Lederman, H. M.
(1998). Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia. Pediatrics
102: 98-100
[Abstract][Full Text]
Stoppa-Lyonnet, D., Soulier, J., Lauge, A., Dastot, H., Garand, R., Sigaux, F., Stern, M.-H.
(1998). Inactivation of the ATM Gene in T-Cell Prolymphocytic Leukemias. Blood
91: 3920-3926
[Abstract][Full Text]
Platzer, M., Rotman, G., Bauer, D., Uziel, T., Savitsky, K., Bar-Shira, A., Gilad, S., Shiloh, Y., Rosenthal, A.
(1997). Ataxia-Telangiectasia Locus: Sequence Analysis of 184 kb of Human Genomic DNA Containing the Entire ATM Gene. Genome Res
7: 592-605
[Abstract][Full Text]
Brown, K. D., Ziv, Y., Sadanandan, S. N., Chessa, L., Collins, F. S., Shiloh, Y., Tagle, D. A.
(1997). The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc. Natl. Acad. Sci. USA
94: 1840-1845
[Abstract][Full Text]
Chen, G., Lee, E. Y.-H. P.
(1996). The Product of the ATM Gene Is a 370-kDa Nuclear Phosphoprotein. J. Biol. Chem.
271: 33693-33697
[Abstract][Full Text]
Lieberman, H. B., Hopkins, K. M., Nass, M., Demetrick, D., Davey, S.
(1996). A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene. Proc. Natl. Acad. Sci. USA
93: 13890-13895
[Abstract][Full Text]
Hawley, R S, Friend, S H
(1996). Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53.. Genes Dev.
10: 2383-2388
Xu, Y, Baltimore, D
(1996). Dual roles of ATM in the cellular response to radiation and in cell growth control.. Genes Dev.
10: 2401-2410
[Abstract]
Imai, T, Yamauchi, M, Seki, N, Sugawara, T, Saito, T, Matsuda, Y, Ito, H, Nagase, T, Nomura, N, Hori, T
(1996). Identification and characterization of a new gene physically linked to the ATM gene.. Genome Res
6: 439-447
[Abstract]
Kastan, M.
(1995). Ataxia-Telangiectasia -- Broad Implications for a Rare Disorder. NEJM
333: 662-664
[Full Text]
Land, C. E.
(1995). Studies of Cancer and Radiation Dose Among Atomic Bomb Survivors: The Example of Breast Cancer. JAMA
274: 402-407
[Abstract]
Savitsky, K, Bar-Shira, A, Gilad, S, Rotman, G, Ziv, Y, Vanagaite, L, Tagle, D., Smith, S, Uziel, T, Sfez, S, et, al.
(1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science
268: 1749-1753
[Abstract]
Hartwell, L., Kastan, M.
(1994). Cell cycle control and cancer. Science
266: 1821-1828
[Abstract]
Miki, Y, Swensen, J, Shattuck-Eidens, D, Futreal, P., Harshman, K, Tavtigian, S, Liu, Q, Cochran, C, Bennett, L., Ding, W, et, al.
(1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science
266: 66-71
[Abstract]
Wooster, R, Neuhausen, S., Mangion, J, Quirk, Y, Ford, D, Collins, N, Nguyen, K, Seal, S, Tran, T, Averill, D, et, al.
(1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science
265: 2088-2090
[Abstract]
Lerman, C., Croyle, R.
(1994). Psychological Issues in Genetic Testing for Breast Cancer Susceptibility. Arch Intern Med
154: 609-616
[Abstract]
Varmus, H.E., Godley, L.A., Roy, S., Taylor, I.C.A., Yuschenkoff, L., Shi, Y.-P., Pinkel, D., Gray, J., Pyle, R., Aldaz, C.M., Bradley, A., Medina, D., Donehower, L.A.
(1994). Defining the Steps in a Multistep Mouse Model for Mammary Carcinogenesis. Cold Spring Harb Symp Quant Biol
59: 491-499
[Abstract]
(1992). RISK OF CANCER IN ATAXIA-TELANGIECTASIA CARRIERS. JWatch General
1992: 5-5
[Full Text]
Shackelford, R. E., Innes, C. L., Sieber, S. O., Heinloth, A. N., Leadon, S. A., Paules, R. S.
(2001). The Ataxia telangiectasia Gene Product Is Required for Oxidative Stress-induced G1 and G2 Checkpoint Function in Human Fibroblasts. J. Biol. Chem.
276: 21951-21959
[Abstract][Full Text]
Schaffner, C., Idler, I., Stilgenbauer, S., Dohner, H., Lichter, P.
(2000). Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc. Natl. Acad. Sci. USA
97: 2773-2778
[Abstract][Full Text]
Previous
